These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32971537)

  • 21. High mobility group box 1 and Dickkopf-related protein 1 as biomarkers of glucose toxicity, atherogenicity, and lower β cell function in patients with type 2 diabetes mellitus.
    Al-Hakeim HK; Al-Kaabi QJ; Maes M
    Growth Factors; 2022 Nov; 40(5-6):240-253. PubMed ID: 36165005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serum levels of CCL11/eotaxin in schizophrenia.
    Teixeira AL; Reis HJ; Nicolato R; Brito-Melo G; Correa H; Teixeira MM; Romano-Silva MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):710-4. PubMed ID: 18096286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major neurocognitive psychosis: a novel schizophrenia endophenotype class that is based on machine learning and resembles Kraepelin's and Bleuler's conceptions.
    Maes M
    Acta Neuropsychiatr; 2023 Jun; 35(3):123-137. PubMed ID: 36373497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophrenia.
    Xiu MH; Wang DM; Du XD; Chen N; Tan SP; Tan YL; Yang F; Cho RY; Zhang XY
    Psychoneuroendocrinology; 2019 Oct; 108():110-117. PubMed ID: 31255950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory evidence for the psychosis continuum model.
    Mørch RH; Dieset I; Færden A; Hope S; Aas M; Nerhus M; Gardsjord ES; Joa I; Morken G; Agartz I; Aukrust P; Djurovic S; Melle I; Ueland T; Andreassen OA
    Psychoneuroendocrinology; 2016 May; 67():189-97. PubMed ID: 26923849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder.
    Hoseth EZ; Krull F; Dieset I; Mørch RH; Hope S; Gardsjord ES; Steen NE; Melle I; Brattbakk HR; Steen VM; Aukrust P; Djurovic S; Andreassen OA; Ueland T
    Transl Psychiatry; 2018 Mar; 8(1):55. PubMed ID: 29507296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia.
    Xiu MH; Wang D; Chen S; Du XD; Chen DC; Chen N; Wang YC; Yin G; Zhang Y; Tan YL; Cho RY; Soares JC; Zhang XY
    Psychiatry Res; 2018 May; 263():147-153. PubMed ID: 29554544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India.
    Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B
    Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways.
    Maes M; Vojdani A; Geffard M; Moreira EG; Barbosa DS; Michelin AP; Semeão LO; Sirivichayakul S; Kanchanatawan B
    Biomol Concepts; 2019 Nov; 10(1):209-225. PubMed ID: 31734647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased peripheral levels of TARC/CCL17 in first episode psychosis patients.
    Malmqvist A; Schwieler L; Orhan F; Fatouros-Bergman H; Bauer M; Flyckt L; Cervenka S; Engberg G; Piehl F; ; Erhardt S
    Schizophr Res; 2019 Aug; 210():221-227. PubMed ID: 30612841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients.
    Singh B; Bera NK; Nayak CR; Chaudhuri TK
    Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition.
    Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of antipsychotic medication on IL-6/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients.
    Subbanna M; Shivakumar V; Venugopal D; Narayanaswamy JC; Berk M; Varambally S; Venkatasubramanian G; Debnath M
    Psychiatry Clin Neurosci; 2020 Jan; 74(1):64-69. PubMed ID: 31587436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship between Cytokines and Verbal Memory in Individuals with Schizophrenia and Their Unaffected Siblings.
    Rebouças DB; Rabelo-da-Ponte FD; Massuda R; Czepielewski LS; Gama CS
    Neuroimmunomodulation; 2018; 25(5-6):334-339. PubMed ID: 30248668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.
    Kanchanatawan B; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    Neurotox Res; 2018 Apr; 33(3):641-655. PubMed ID: 29380275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated circulating levels of IL-6 in schizophrenia.
    Naudin J; Mège JL; Azorin JM; Dassa D
    Schizophr Res; 1996 Jul; 20(3):269-73. PubMed ID: 8827853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome.
    Maes M; Kanchanatawan B; Sirivichayakul S; Carvalho AF
    Mol Neurobiol; 2019 Jul; 56(7):5122-5135. PubMed ID: 30484113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patients.
    Kirchner SK; Ozkan S; Musil R; Spellmann I; Kannayian N; Falkai P; Rossner M; Papiol S
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):425-431. PubMed ID: 30523404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.